Citations

Showing 10 of 108152 citations.

Copeptin Responses to Isotonic and Hypertonic Saline Infusion in Healthy Adults
Suh, HyunGyu , Sprong, Cameron, Butts, Cory L. , Seal, Adam , Scott, Dylan, Lemetais, Guillaume, Vanhaecke, Tiphaine , Perrier, Erica T. , Kirkland, Tracie , Jansen, Lisa T. , Adams, J.D. , Melander, Olle , Dolci, Alberto, Kavouras, Stavros A.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.597.2 Get It

Copeptin, a c‐terminal segment of arginine vasopressin (AVP) prohormone, has equimolar secretion to AVP in response to osmotic, stress‐related, and hemodynamic stimulation. For this reason, and because of the difficulties in measuring AVP directly linked to its short half‐life, copeptin has been used as a stable and sensitive surrogate marker for AVP for various clinical indications. However, the plasma copeptin response to osmotic stimulation remains poorly documented. PURPOSE Examine the plasma copeptin response to plasma hyperosmolality induced by hypertonic saline infusion. METHODS Sixty healthy adults (50% male, age: 30±1 y, weight: 78.2±15.2 kg, body mass index: 26.9±4.0 kg·m −2 ) were infused intravenously with 3% (HYPER) or 0.9% (ISO) NaCl for 2 h (0.1 ml·kg −1 ·min −1 ) in a counterbalanced, cross‐over design. Blood samples were collected every 30 minutes. Plasma osmolality (P Osm ), copeptin (P Cop ; BRAHAMS copeptin proAVP, Thermo Fisher Scientific, Germany), and sodium (P Na ) were measured, and changes in plasma volume (PV) were calculated from hematocrit and hemoglobin using the Dill & Costill equation. RESULTS Following the HYPER trial, P Na increased from 136±2 mmol ·L −1 to 146.5±3 mmol ·l −1 ( P < 0.001), with PV expansion of 18.7±7.3% ( P < 0.001). Both P Osm and P Cop increased significantly (0 min: 286±3 mmol·kg −1 and 4.5±3.7 pmol·L −1 ; 120 min: 305±4 mmol·kg −1 and 20.4±12.8 pmol·L −1 , respectively, P < 0.001). Mean (95% CI) P Cop increased with increasing P Osm : 3.2 (2.5–3.8) pmol·L −1 for P Osm ≤ 284.9 mmol·kg −1 ; 5.4 (3.8–7.0) pmol·L −1 for P Osm 285–289.9; 6.2 (4.3–8.0) pmol·L −1 for P Osm 290–294.9; 8.5 (7.1–9.9) pmol·L −1 for P Osm 295–299.9; 12.3 (10.2–14.4) pmol·L −1 for P Osm 300–304.9; and 19.2 (16.3–22.2) pmol·L −1 for P Osm ≥ 305 mmol·kg −1 . In contrast, during the ISO trial P Na remained unchanged during the 2‐h infusion (135.9±1.9 vs. 137.6±1.6 mmol·L −1 ), while PV expanded by 10.5±4.4% ( P < 0.001 compared to baseline; P < 0.001 compared to HYPER). Neither P Osm (0 min: 285±4,120 min: 287±3 mmol·kg −1 ) nor P Cop (0 min: 4.1±1.8, 120 min: 3.8±3.0 pmol·L −1 ) were affected during the ISO trial. CONCLUSION Plasma copeptin was stimulated by increased plasma osmolality during a hypertonic infusion. Support or Funding Information This research was supported by Danone Research This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Pharmacological Assessment of the Contribution of the Arterial Baroreflex to Sympathetic Discharge Patterns in Healthy Humans
Ott, Elizabeth P., Nicholson, Wayne T. , Shoemaker, J. Kevin , Limberg, Jacqueline K. , Shoemaker, J Kevin , Baker, Sarah E. , Joyner, Michael J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.595.1 Get It

Objective We examined the contribution of the arterial baroreflex to sympathetic discharge patterns in humans by systematically manipulating the reflex using intravenous nitroprusside and phenylephrine. We hypothesized nitroprusside would increase firing of low‐threshold axons, with no effect on recruitment of latent axons and/or synaptic delays. We further hypothesized phenylephrine would decrease firing of low‐threshold axons, with no effect on synaptic delays. Methods Heart rate (HR, ECG), arterial blood pressure (BP, brachial arterial catheter), and multi‐unit muscle sympathetic nerve activity (MSNA, microneurography of the peroneal nerve) were measured in 13 male subjects (30±2 yrs, 25±1 kg/m 2 ) at baseline and during systemic intravenous infusion of nitroprusside (0.4–1.7 μg/kg/min) and phenylephrine (0.2–1.0 μg/kg/min), administered separately. Action potential (AP) patterns were studied from the filtered raw signal using wavelet‐based methodology. Results Compared to baseline, BP decreased and HR and multi‐unit MSNA (41±5 to 53±4 bursts/100 heart beats) increased with nitroprusside (all P <0.01). Nitroprusside increased AP incidence (326±66 to 579±129 AP/100 heart beats) and AP content per integrated burst (8±1 to 11±2 AP/burst) (all P <0.01). The firing probability of low‐threshold axons increased with nitroprusside, and recruitment of previously latent, high‐threshold axons was observed (22±3 to 24±3 max clusters, 9±1 to 11±1 clusters/burst; all P <0.05). Compared to baseline, BP increased and HR and multi‐unit MSNA (41±3 to 21±3 bursts/100 heart beats) decreased with phenylephrine (all P <0.01). Phenylephrine decreased AP discharge rate (406±128 to 166±42 AP/100 heart beats) and resulted in fewer unique clusters (15±2 to 9±1 max clusters, all P <0.05); however, components of an integrated burst were not altered (9±2 vs 8±1 AP/burst; 5±1 vs 4±1 clusters/burst, P >0.05). AP cluster latency decreased with cluster size under both conditions ( P <0.01), but this relationship was not altered with nitroprusside ( P =0.42) or phenylephrine ( P =0.39). Conclusions Baroreflex unloading with systemic nitroprusside increases sympathetic neuronal discharge rate by increasing the firing probability of low‐threshold axons, in addition to recruitment of previously latent, high‐threshold axons. In contrast, baroreflex loading with systemic phenylephrine decreases neuronal discharge rate, including decreased firing probability of high‐threshold axons; however, the components of an integrated burst (AP and clusters per burst) and synaptic delays are unaffected. These data support a hierarchical pattern of sympathetic neural recruitment/de‐recruitment and suggest acute modification of synaptic delays are not influenced by the baroreflex. Support or Funding Information NIH HL083947, NIH HL130339 This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
The Role of the Paravertebral Ganglia in Sympathetic Vasoconstrictor Neural Discharge Patterns
Limberg, Jacqueline K. , Nicholson, Wayne T. , Shoemaker, J. Kevin , Shoemaker, J Kevin , Klassen, Stephen A. , Baker, Sarah E. , Curry, Timothy B. , Joyner, Michael J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.594.3 Get It

Action potentials (APs) of varying sizes and firing probabilities, that are synchronized into bursts of efferent traffic, characterize recordings of muscle sympathetic nerve activity (MSNA). Recent evidence points to ordered recruitment of these APs but the sites of this control remain unknown. This study investigated the role of the paravertebral ganglia in sympathetic AP emission patterns using pharmacological blockade of ganglionic N N ‐nicotinic receptors via trimethaphan camsylate (TM; n = 7 females, 37 ±5 years, 112 ±2/70 ±3 mmHg, 22 ±1 kg/m 2 ). Heart rate (HR; ECG), blood pressure (BP; arterial catheter) and MSNA (microneurography) were recorded during baseline, TM infusion (1–7 mg/min) and Valsalva's manoeuvre. MSNA APs were detected from the filtered raw signal using a wavelet deconstruction approach and were binned in clusters (Scott's rule) based on peak‐to‐peak amplitude (K‐means). In the final minute of MSNA burst detection during TM, HR increased (57 ±11 to 66 ±12 bpm) and mean BP decreased (97 ±7 to 90 ±7 mmHg) (both P < 0.01 compared to baseline). Relative to baseline, TM elicited a progressive reduction in total sympathetic outflow (833 ±458 to 157 ±120 AU/min), characterized by fewer integrated bursts (30 ±14 to 9 ±8 bursts/100 beats) with decaying amplitude (49 ±3 to 31 ±3 AU) (all P < 0.01). Underlying TM‐mediated attenuations in integrated MSNA were reductions in AP incidence (186 ±101 to 29 ±31 AP/100beats) and AP content per integrated burst (7 ±2 to 3 ±1 APs/burst) (all P < 0.01). Compared to baseline, the total number of active AP clusters was reduced with TM (14 ±3 to 9 ±3 AP clusters), resulting in fewer unique clusters per burst (4 ±1 to 3 ±1 AP clusters/burst) (both P < 0.01). Relative to baseline, most participants demonstrated a reduction in the within‐burst firing probability of all AP clusters, with the largest two to six AP clusters ceasing to fire in the last minute before integrated bursting activity was abolished. Following cessation of integrated MSNA bursts, the smallest 6 ±2 sympathetic AP clusters (range: 4 – 8 AP clusters) persisted to fire in an asynchronous pattern (49 ±41 AP/100beats) in all participants. Valsalva's Maneuver did not increase the incidence of these persistent small APs (60 ±42 AP/100beats, P = 0.52), or instigate any larger APs (previously active at baseline) in six of seven participants (6 ±1 total AP clusters, P = 0.30). These data suggest: 1) the paravertebral ganglia may contribute to the heterogeneity in the firing probabilities of varying sized postganglionic sympathetic APs active under baseline conditions, and 2) the presence of non‐synchronized sympathetic APs that express resistance to blockade with trimethaphan. Support or Funding Information Supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada, Discovery Grant #217916‐2013. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
“The Role of the Unfolded Protein Response in Mediating Adaptations to Exercise Responsiveness”
Hart, Corey R., Dasari, Surendra , Lalia, Antigoni Z., Koh, Jin‐Ho , Lanza, Ian R.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.587.13 Get It

Aging is associated with altered mitochondrial physiology and exercise responsiveness in skeletal muscle. Activation of the unfolded protein response in the endoplasmic reticulum (UPR ER ) and mitochondria (UPR MT ) is linked with exercise‐induced adaptations in skeletal muscle, but the possibility that these processes impact exercise responsiveness and mitochondrial function in older humans has not been fully elucidated. The purpose of this study was to evaluate age‐related changes in UPR ER and UPR MT gene transcripts and protein abundance in response to a single bout of exercise. Muscle biopsies were obtained from 12 young (27±5 yr) and 12 older (75±5 yr) well‐matched, healthy men and women before exercise and 18h following a single bout of unilateral leg extension. Before exercise, a gene set enrichment analysis (GSEA) revealed that 27 genes associated with the UPR ER were upregulated in the older subjects compared to the young (enrichment false discovery rate [FDR] = 0.0842). After exercise, GSEA indicated upregulated UPR ER genes in both the young (FDR = 0.0405) and older subjects (FDR = 0.0619), however, pathway activation analysis revealed significantly greater activation of UPR ER and UPR MT gene transcripts post‐exercise in the younger subjects ( P < 0.05). In contrast, age did not affect key UPR‐regulatory protein abundance 18h post‐exercise. Interestingly, statistically significant correlations were observed in the young subjects between the mitochondrial transcriptional coactivator, peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α) and key regulatory genes associated with the UPR ER (GRP78, R = 0.67; ATF6, R = 0.70) and the UPR MT (HSPE1, R = 0.61; HSPD1, R = 0.55; and HSPA9, R = 0.79), which were not evident in the older subjects. In conclusion, transcriptomic analysis revealed an age‐related decline in the adaptive UPR ER and UPR MT transcriptional response following a single bout of exercise that could potentially explain, in part, impaired exercise responsiveness and mitochondrial dysfunction with age. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Plasminogen Activator Inhibitor‐1 after Acute Myocardial Infarction in Obstructive Sleep Apnea Patients
Svatikova, Anna , Gami, Apoor S., Singh, Prachi , Kuniyoshi, Fatima H. Sert , Somers, Virend K.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.572.1 Get It

Background Acute cardiac and vascular events, including myocardial infarction (MI) exhibit a peak onset between 6 AM and 11 AM. Plasminogen activator inhibitor‐1 (PAI‐1) is a main inhibitor of tissue‐plasminogen activator and a key indicator of prothrombotic state. Elevated levels of PAI‐1 have been linked to increased cardiac and vascular risk. Obstructive sleep apnea (OSA) has also been associated with increased risk of MI. Hypoxemia, as well as OSA, increase PAI‐1. We tested the hypothesis that the early morning after awakening is associated with higher PAI‐1 activity in subjects with acute MI who also have OSA. Methods We studied 56 subjects after acute myocardial infarction (mean age 60±2 years; BMI 28±1 kg/m 2 ). All subjects underwent complete overnight sleep polysomnography within 2 weeks after MI to assess for presence and severity of OSA. PAI‐1 activity was measured in all 56 subjects, first before sleep (at 9 PM), and then immediately after awakening in the morning (at 6 AM). A third measurement of PAI‐1 was obtained in all subjects at 11 AM. Results For the group, PAI‐1 activity almost doubled from 12.5±1.6 U/mL at 9 PM to 22.5±2.5 U/mL after waking at 6 AM and decreased to 14.2±2.4 U/mL by 11 AM (P<0.0001). Fifty seven percent of patients were observed to have OSA, with apnea hypopnea index of >10 events/hour. Sleep apnea did not contribute to further elevation of morning PAI‐1 activity level in acute MI patients (9 PM, 6 AM and 11 AM PAI‐1 activity respectively: no OSA 11.6±2.5 U/mL, 24.1±3.8 U/mL and 15.2±3.5 U/mL; OSA 13.3±2.1 U/mL, 21.1±3.3 U/mL and 13.3±3.3 U/mL; P=0.8 for between group comparison). Conclusions Increased PAI‐1 activity in acute MI patients may be an important mechanism underlying the early morning peak in cardiovascular events. The presence of OSA however does not appear to further accentuate the already elevated PAI‐1 activity in acute MI patients. In patients after acute MI, the diurnal variation in PAI‐1, rather than apnea, may drive the impaired fibrinolysis. Support or Funding Information ‐‐R01 grant HL65176‐‐This study was also supported in part by a gift to the Mayo Foundation by the Philips Respironics Foundation. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Association between high fat consumption, myelin loss, and mitochondrial dynamics
Yoon, Hyesook, Kim, Ha-Neui, Kleppe, Laurel S., Simon, Whitney L., Matveyenko, Aleksey V. , Scarisbrick, Isobel A. , Langley, Monica R. , Lanza, Ian R. , LeBrasseur, Nathan K.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.543.15 Get It

We recently demonstrated that high dietary fat (HFD) consumption results in a dramatic loss of myelinating cells and their progenitors in the adult CNS (Yoon et al., 2016). However, the mechanism(s) by which HFD drives dysmyelination are unknown. Since epidemiological studies indicate that metabolic syndrome is a key risk factor for multiple sclerosis (MS), a better understanding of how HFD contributes to oligodendrocyte loss and the capacity for myelin regeneration has the potential to highlight new treatment targets. In mice fed HFD, we found significant decreases in vertical activity by 4 wk and significant changes in ambulatory and stereotypy movements by 12 wk in the Open Field Test. HFD‐fed mice also spent less time in the center of the field as opposed to the perimeter, indicating an anxious phenotype. Mitochondrial isolated from the spinal cord of mice consuming HFD for 4 wk had significantly higher state 3 and state 4 respiration as determined by high‐resolution respirometry. However, by 12 wk, state 4 mitochondrial respiration was significantly less in the HFD group. Targeted LC‐LC‐mass spectroscopy approaches demonstrated that Citric Acid Cycle intermediates are also depleted in the spinal cord of mice consuming HFD for 12 wk compared to controls. Changes in genes related to mitochondrial morphology, quality control processes, and oxidative stress response were also found. In addition, there were significantly fewer Olig2+ cells and increased signs of lipid peroxidation products (4‐Hydroxynonenal‐immunoreactivity) in the corpus callosum of HFD consuming mice compared to those fed a regular diet. Supporting in vivo findings that oligodendrocytes are reduced in the spinal cord of mice consuming HFD, we observed increased mitochondrial fragmentation and a reduced oxygen consumption rate in oligodendrocyte precursors cultured with palmitic acid. Astrocytes however, significantly increased oxygen consumption following exposure to palmitic acid. Together, these findings suggest that changes in the adult spinal cord in response to HFD consumption creates an environment that is less conducive to neural repair by impacting mitochondria function and morphology and impairing oligodendrocyte function. To determine any impact of HFD on myelin regeneration, studies are ongoing to examine myelin regeneration using a murine model of Cuprizone‐mediated demyelination. Neurobehavioral assessments to date reveal significant interactions between HFD and myelin injury and repair. Understanding the cellular environment in response to dietary factors such as HFD consumption can help to guide care for individuals with MS and other conditions in which myelin loss plays a pathological role and has potential to identify new targets for intervention. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Twin Talk Series: A novel method to foster peer‐to‐peer pedagogical training
Brown, Ashley K. , Matchett, William E. , Horazdovsky, Bruce , Martínez‐Gálvez, Gabriel , Coffman, Kirsten E.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.535.26 Get It

Mayo Clinic annually trains over 1000 predoctoral students and postdoctoral research fellows in medicine and biomedical sciences. However, training opportunities are limited for those interested in teaching and mentoring methodologies. Therefore, Mayo Clinic predoctoral students sought to provide trainee‐led learning opportunities for fellow trainees. A survey was sent to all Mayo Clinic predoctoral and postdoctoral trainees to determine preferences for pedagogy education formats. In response to survey results, the Twin Talk Series was developed. A Twin Talk is a set of one‐hour talks comprised of a Take‐in session and one or more Try‐out session(s). At the Take‐in session, a content expert discusses a pedagogical technique, and at the following Try‐out session(s), trainee volunteers practice the technique among themselves. Eight Twin Talks have been organized to date on several teaching techniques and pedagogical development topics. The impact of each Twin Talk, including understanding, format, and interest level, was evaluated through survey tools. Survey results suggested trainees favored in‐person pedagogy expert presenters during the Take‐in session over video conferences. Furthermore, modeling of the teaching technique by the expert presenter during the Take‐in session was well‐received. However, participation in the follow‐up Try‐out practice session was limited. Overall, the Twin Talk Series is a promising method for trainee‐led, peer‐to‐peer pedagogy education, particularly at institutions with limited access to pedagogical resources. The Twin Talk Series will continue to be refined to increase trainee participation, particularly in the follow‐up Try‐out sessions, and to provide relevant opportunities for trainees to practice teaching. Support or Funding Information Mayo Foundation of Medical Education and Research This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Seven‐In‐Absentia (SINA) Family E3 Ligases in Development and Growth
Cao, Yajun , Sciver, Robert E. Van , Ahmed, Atique U. , Tang, Amy

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.533.52 Get It

The RAS signal transduction cascade is a pivotal signaling pathway that controls numerous fundamental cellular processes, such as cell proliferation, differentiation, motility, and apoptosis. Oncogenic K‐RAS pathway activation is detected in approximately 30% of all human cancers. Seven‐IN‐Absentia (SINA) is an evolutionarily conserved E3 ubiquitin ligase that is the most downstream signaling module identified in the RAS signaling pathway. Underscoring the importance of SINA is its high evolutionary conservation with over 83% amino acid identity shared between Drosophila SINA and its human SINA homologs (SIAHs). As a major signaling hub and the downstream signaling “gatekeeper” in the RAS pathway, SIAHs are uniquely positioned to inhibit “undruggable” oncogenic K‐RAS activation that is prevalent in high‐grade metastatic cancer. Thus, it is important to delineate the enzymatic activity, molecular regulation, and substrate targeting mechanism(s) of this highly conserved family of SINA/SIAH E3 ligases. By deploying the elegant and powerful Drosophila photoreceptor cell development system, we conducted a genetic modifier screen and identified 28 new sina mutant alleles that exhibit a range of mutant phenotypes. For example, sina complete loss of function (null alleles) is cell lethal, suggesting that SINA is an essential gene in development. All other sina mutant alleles exhibit stronger phenotypes than the previously published sina 2 and sina 3 alleles, providing us with an opportunity to study sina loss‐of‐function mutant phenotypes. Sequencing analysis of these newly identified mutant alleles reveals the critical roles of several immutatable amino acid residues essential for SINA function. To demonstrate the functional conservation of SINA/SIAH proteins, we have generated a collection of transgenic fly lines that carry either wild‐type (WT) or dominant negative (DN) Dm SINA and human SIAH. The altered Dm SINA/hSIAH expression under the control of sev ‐, GMR ‐, and dpp ‐ and salivary gland ‐GAL4 drivers revealed the biological consequences of gain of function and/or loss of function of Dm SINA/hSIAH1/2 in transmitting RAS signaling in central nervous system (CNS) and peripheral nervous system (PNS) development. Immunofluorescent staining of developing imaginal discs and electron micrographs of adult tissues show that ectopic expression of SINA WT/DN /SIAH WT/DN in neurons resulted in dramatic changes in neuronal cell fate in the developing eye and notum. Furthermore, immunofluorescent staining of larval salivary glands revealed a critical role for SINA family E3 ligases in regulation of cell shape, focal adhesions, and cellular junctions. The results from these transgenic animals suggested that Drosophila SINA and human SIAH1/SIAH2 are evolutionarily conserved and functionally interchangeable. Through this developmental neurobiology and cellular biology‐based study, we aim to dissect the molecular action of SINA/SIAH1/2 in RAS signaling. Furthermore, we hope to translate these findings to demonstrate the anticancer efficacy of the next‐generation anti‐SIAH‐based anti‐K‐RAS strategy against high‐grade metastatic human cancer in the future. Support or Funding Information Extramural funding support provided by NIH NIGMS R01 GM069922Z‐05S1 and NCI R01 CA140550. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Expression and Purification of human Neuronal PAS domain protein 2 (hNPAS2)
Moriel, Karla , Xi, Dongman, Sarabia, Alejandro, Chauhan, Neha , Ray, Supriyo , Xiao, Chuan

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.526.15 Get It

The circadian rhythm is an internal clock responsible for a variety of physiological processes occurring within a 24‐hour cycle. Synchronized by a master clock in the brain, the circadian rhythm consists of a transcriptional‐translational feedback loop (TTFL) capable of inducing oscillating gene expression in all the cells throughout the organism. The TTFL begins with the heterodimerization of two transcription factors, BMAL1 and CLOCK, resulting in the transcription and translation of many circadian‐related genes. The target protein of interest, human neuronal PAS domain protein 2 (hNPAS2) is a paralog of CLOCK that can serve as a positive regulator of the circadian rhythm by heterodimerizing with BMAL1. Previous research suggests that disruption in the expression of hNPAS2 may result in improper circadian functioning and development of sleeping and mental disorders. In this study, the full‐length eukaryotic form of hNPAS2 was cloned into a bacterial expression vector. However, bacterial expression has led to misfolding and aggregation of the recombinant hNPAS2, becoming the central issue of the study. In an effort to obtain soluble and homogeneous hNPAS2, multiple expression and purification methods have been developed. The resultant purified soluble protein will enable future structural and functional studies, which can bring new insights to the regulatory mechanisms of the circadian rhythm and understanding of circadian‐related disorders. Additionally, a portion of this research was integrated into a teaching module delivered by the leading student researcher to a senior undergraduate advanced biochemistry course. Multiple novel pedagogic techniques were employed in the teaching module with the objective of raising the students' interests to research as well as their abilities to apply the principles and concepts of biochemistry learned in the course in a real scientific study. Support or Funding Information Research reported in this poster was supported by the National Institute of General medical Sciences of the National Institutes of Health under linked Award Numbers RL5GM118969, TL4GM118971, AND UL1GM118970. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health Research reported in this poster was supported by the National Research of General Medical Sciences of NIH under award number SC3GM109870 Research reported in this poster was supported has used core facility at BBRC supported by National Institute of Minority Health and Health Disparities under award number 5G12MD007592 This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Impact of Menopausal Hormone Treatments on Intravascular Cellular Activation and Development of White Matter Hyperintensities in Healthy Postmenopausal Women
Jayachandran, Muthuvel , Lahr, Brian D. , Miller, Virginia M. , Kantarci, Kejal

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 32 | Issue: S1 | Pages: No page available

10.1096/fasebj.2018.32.1_supplement.517.7 Get It

Objective Blood thrombogenicity and vascular inflammation may influence development of white matter hyperintensities (WMH) in the brain. This study aimed to determine if menopausal hormone treatments (MHT) modified that association in recently menopausal women who were enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) at Mayo Clinic. Methods Women (n=95) underwent MRI prior to and at 18, 36 and 48 months after randomization to either transdermal 17β‐estradiol (tE2, n=30), conjugated equine estrogen (oCEE, n=29) both with progesterone for 12 days per month or placebo pills and patch (PBO, n=36). Fasting blood was analyzed for a set of 14 activation markers of platelets and endothelial cells, inflammation, and thrombogenicity. Principal components (PC) analysis was used to reduce dimensionality of these markers, and the first 5 PC identified were then assessed for association with treatment and changes in WMH. Results WMH increased in all groups over the 48 months of treatment with greater increases in the oCEE compared to tE2 and PBO (P=0.015). The 5 PC explained 62% of the variation in cellular activation markers. A global test of these 5 PC revealed a borderline association with treatment group (P=0.059), with the PC reflecting total platelet count, platelet microaggregates and ATP secretion showing higher scores in the oCEE compared to the other groups (P=0.006). The change in WMH over the 48 months of MHT showed an overall association with the 5 PC (P=0.026), the most prominent of which was the first PC reflecting vascular inflammation by number of blood microveicles (MV) from activated monocytes and endothelial cells and MV positive for intercellular adhesion molecule 1 (P=0.001). There was no evidence that this association differed by MHT. Conclusion Markers of blood thrombogenicity and inflammation may influence development of WMH in the brain but this relationship may be influenced by factors other than the type of MHT used in the KEEPS study. Support or Funding Information NIH P50 AG44170 This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .